Company: Merck & Company Inc. (MRK)
*DRIP Club Members are able to acquire or list a share of a company on the DRIP Exchange Page.
Company Profile: Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm’s immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company’s sales are generated in the United States. -Morningstar.com-
Symbol: MRK
Recent Price: $112.15
Dividends: $3.08
Yield: 2.75%
Sector: Healthcare
Industry: Drug Manufacturers-General
Address & Company Phone #: 2000 Galloping Hill Rd. Kenilworth NJ 07033, 908-740-4000
Transfer Agent: Equiniti Group plc. 800-522-9114
Moody’s Rating: A1
Minimum & Maximum Investment: $50 – $50,000/year
Investment Dates: Every Tuesday
Shares to Qualify: 1 Share or $350
Fees: Div.: $1 (to $2)+3¢/sh. Cash: $4+3¢/sh. Cert: $0 Sells: by Mail, Fax or Phone for $10+10¢/sh.
52 Week High & Low: $129.29, $99.14